- ►annals.org [PDF] LD May, JH Lefkowitch, MT Kram, DE Rubin - Annals of internal medicine, 2002 - Am Coll Physicians Louis D. May, MD; Jay H. Lefkowitch, MD; Michael T. Kram, MD; and David E.
Rubin, MD ... Background: Pioglitazone is an oral hypoglycemic agent in the
thiazolidinedione class. Only one case of hepatotoxicity related to this ... Cited by 86 - Related articles - All 6 versions
K Maeda - Annals of internal medicine, 2001 - ncbi.nlm.nih.gov 1: Ann Intern Med. 2001 Aug 21;135(4):306. Hepatocellular injury in a patient
receiving pioglitazone. Maeda K. Publication Types ... Cited by 69 - Related articles - BL Direct
MP Chase, JC Yarze - The American journal of gastroenterology, 2002 - cat.inist.fr Pioglitazone-associated fulminant hepatic failure. Michael P CHASE, Joseph
C YARZE The American journal of gastroenterology 97:22 ... Cited by 32 - Related articles - BL Direct - All 6 versions
HL Bonkovsky, R Azar, S Bird, G Szabo, B … - Digestive diseases and sciences, 2002 - Springer Troglitazone maleate (Rezulin) has been associated with severe hepatotoxicity,
which led to its withdrawal from the US market in March 2000. Rosiglitazone
maleate (Avandia) is being marketed as a safe alternative in the treatment ... Cited by 41 - Related articles - BL Direct - All 5 versions
LM Forman, DA Simmons, RH Diamond - Annals of internal medicine, 2000 - Am Coll Physicians Lisa M. Forman, MD; David A. Simmons, MD; and Robert H. Diamond, MD ...
Background: Rosiglitazone maleate is the second ap- proved oral hypoglycemic
agent of the thiazolidinedione class. The first, troglitazone, has been ... Cited by 180 - Related articles - BL Direct - All 7 versions
- ►annals.org [PDF] J Al-Salman, H Arjomand, DG Kemp, M Mittal - Annals of internal medicine, 2000 - Am Coll Physicians Jameela Al-Salman, MD; Heider Arjomand, MD; David G. Kemp, MD; and Manoj Mittal,
MD ... Background: Rosiglitazone maleate (Avandia, SmithKline Beecham,
Philadelphia, Pennsylvania) is a new oral hypo- glycemic agent approved for ... Cited by 181 - Related articles - BL Direct - All 6 versions
HE Gouda, A Khan, J Schwartz, RI Cohen - The American Journal of Medicine, 2001 - Elsevier An 82-year-old man was admitted with a 3-week history of malaise, nausea, and
generalized weakness. He had a history of diabetes, coronary artery disease,
cholecystectomy, and a chromophilic pituitary adenoma that was treated ... Cited by 32 - Related articles - BL Direct - All 6 versions
AG Pinto, OW Cummings, N Chalasani - Annals of internal medicine, 2002 - ncbi.nlm.nih.gov 1: Ann Intern Med. 2002 Nov 19;137(10):857. Severe but reversible cholestatic liver
injury after pioglitazone therapy. Pinto AG, Cummings OW, Chalasani N. ... Cited by 21 - Related articles - BL Direct - All 3 versions
M Dhawan, R Agrawal, J Ravi, S Gulati, J … - Journal of clinical gastroenterology, 2002 - journals.lww.com Medications often are used in conjunction with diet and exercise to control
hyperglycemia in patients with type II diabetes. Besides injectable insulin,
several oral agents are administered such as biguanides, sulfonylureas, and ... Cited by 28 - Related articles - BL Direct - All 5 versions
S Nagasaka, T Abe, A Kawakami, I Kusaka, T … - Diabetic medicine: a journal of the British Diabetic …, 2002 - ncbi.nlm.nih.gov 1: Diabet Med. 2002 Apr;19(4):347-8. Pioglitazone-induced hepatic injury
in a patient previously receiving troglitazone with success. ... Cited by 23 - Related articles - BL Direct - All 5 versions
